Longer and better lives for patients with atrial fibrillation : the 9th AFNET/EHRA consensus conference
Linz, Dominik (University of Copenhagen)
Andrade, Jason G. (Montreal Heart Institute)
Arbelo, Elena (Hospital Clínic i Provincial de Barcelona)
Boriani, Giuseppe (University of Modena and Reggio Emilia)
Breithardt, Guenter (Atrial Fibrillation NETwork (AFNET))
Camm, A.John (Clinical Sciences Institute. St. George's University of London)
Caso, Valeria (University of Perugia)
Nielsen, Jens Cosedis (Aarhus University)
De Melis, Mirko (Bakken Research Center)
De Potter, Tom (OLV Hospital)
Dichtl, Wolfgang (Medical University Innsbruck)
Diederichsen, Søren Zoega (Copenhagen University Hospital)
Dobrev, Dobromir (University Duisburg-Essen)
Doll, Nicolas (Schüchtermann-Klinik)
Duncker, David (Hannover Medical School)
Dworatzek, Elke (Pfizer Pharma GmbH)
Eckardt, Lars (University Hospital of Münster (Alemanya))
Farkowski, Michal M (Preventicus GmbH)
Fabritz, Larissa (University of Birmingham)
Farkowski, Michal (National Medical Institute)
Filgueiras-Rama, David (Instituto de Investigación Sanitaria del Hospital Clínico San Carlos)
Goette, Andreas (St Vincenz-Hospital Paderborn)
Guasch, Eduard (Hospital Clínic i Provincial de Barcelona)
Hack, Guido (Bristol-Myers Squibb GmbH and Co. KGaA)
Hatem, Stéphane (Hospital de la Pitié-Salpêtrière (París, França))
Haeusler, Karl Georg (Universitätsklinikum Würzburg)
Healey, Jeff S. (Population Health Research Institute)
Heidbuechel, Hein (University of Antwerp)
Hijazi, Ziad (Uppsala University)
Hofmeister, Lucas H. (Global Medical Affairs Bayer AG)
Hove-Madsen, Leif (Institut de Recerca Sant Pau)
Huebner, Thomas (Preventicus GmbH)
Kääb, Stefan (Munich Heart Alliance)
Kotecha, Dipak (University Hospitals Birmingham NHS Trust)
Malaczynska-Rajpold, Katarzyna (Guy's and St Thomas' NHS Foundation Trust)
Merino, Katarzyna (Hospital Universitario La Paz (Madrid))
Metzner, Andreas (University Heart and Vascular Center Hamburg)
Mont, Lluís (Hospital Clínic i Provincial de Barcelona)
Andre Ng, Ghulam (NIHR Leicester Biomedical Research Centre)
Oeff, Michael (Medizinische Hochschule Brandenburg)
Parwani, Abdul Shokor (Deutsches Herzzentrum der Charité (CVK))
Puererfellner, Helmut (Ordensklinikum Linz Elisabethinen)
Ravens, Ursula (University Clinic Freiburg)
Rienstra, Michiel (University of Groningen)
Sanders, Prashanthan (Royal Adelaide Hospital)
Scherr, Daniel (Medical University of Graz)
Schnabel, Renate B (University Medical Center Hamburg-Eppendorf)
Hove-Madsen, Leif (Maastricht University)
Sohns, Christian (Klinik für Elektrophysiologie-Rhythmologie)
Steinbeck, Gerhard (Center for Cardiology at Clinic Starnberg)
Steven, Daniel (University Hospital Cologne (Colònia, Alemanya))
Toennis, Tobias (University Medical Center Hamburg-Eppendorf)
Tzeis, Stylianos (Mitera Hospital)
van Gelder, Isabelle C. (University of Groningen)
van Leerdam, Roderick H. (Royal Philips)
Vernooy, Kevin (Maastricht University Medical Center)
Wadhwa, Manish (Philips Ambulatory Monitoring and Diagnostics)
Wakili, Reza (German Centre for Cardiovascular Research (DZHK))
Willems, Stephan (Asklepios Hospital St. Georg)
Witt, Henning (Pfizer Pharma GmbH)
Zeemering, Stef (Maastricht University)
Kirchho, Paulus (University Heart and Vascular Center Hamburg)
Universitat Autònoma de Barcelona

Fecha:	2024
Resumen:	Aims Recent trial data demonstrate beneficial effects of active rhythm management in patients with atrial fibrillation (AF) and support the concept that a low arrhythmia burden is associated with a low risk of AF-related complications. The aim of this document is to summarize the key outcomes of the 9th AFNET/EHRA Consensus Conference of the Atrial Fibrillation NETwork (AFNET) and the European Heart Rhythm Association (EHRA) Methods Eighty-three international experts met in Münster for 2 days in September 2023. Key findings are as follows: (i) Active rhythm and results management should be part of the default initial treatment for all suitable patients with AF. (ii) Patients with device-detected AF have a low burden of AF and a low risk of stroke. Anticoagulation prevents some strokes and also increases major but non-lethal bleeding. (iii) More research is needed to improve stroke risk prediction in patients with AF, especially in those with a low AF burden. Biomolecules, genetics, and imaging can support this. (iv) The presence of AF should trigger systematic workup and comprehensive treatment of concomitant cardiovascular conditions. (v) Machine learning algorithms have been used to improve detection or likely development of AF. Cooperation between clinicians and data scientists is needed to leverage the potential of data science applications for patients with AF. Conclusions Patients with AF and a low arrhythmia burden have a lower risk of stroke and other cardiovascular events than those with a high arrhythmia burden. Combining active rhythm control, anticoagulation, rate control, and therapy of concomitant cardiovascular conditions can improve the lives of patients with AF.
Ayudas:	Agencia Estatal de Investigación PID2020-116927RB-C21
Derechos:	Aquest document està subjecte a una llicència d'ús Creative Commons. Es permet la reproducció total o parcial, la distribució, la comunicació pública de l'obra i la creació d'obres derivades, sempre que no sigui amb finalitats comercials, i sempre que es reconegui l'autoria de l'obra original.
Lengua:	Anglès
Documento:	Article ; recerca ; Versió publicada
Materia:	AFNET ; Anticoagulation ; Artificial intelligence ; Atrial cardiomyopathy ; Atrial fibrillation ; Biomarkers ; Bleeding ; Catheter ablation ; Cognitive function ; Consensus statement ; Cost ; Dementia ; EHRA ; Guidelines ; Heart failure ; Integrated care ; Outcomes ; Quality of care ; Research ; Research priorities ; Rhythm management ; Screening ; Stroke ; Technology
Publicado en:	Europace, Vol. 26 Núm. 4 (april 2024) , ISSN 1532-2092

DOI: 10.1093/europace/euae070
PMID: 38591838

18 p, 2.4 MB

El registro aparece en las colecciones:
Documentos de investigación > Documentos de los grupos de investigación de la UAB > Centros y grupos de investigación (producción científica) > Ciencias de la salud y biociencias > Institut de Recerca Sant Pau
Artículos > Artículos de investigación
Artículos > Artículos publicados